Targeted axillary dissection with 125i seed placement before neoadjuvant chemotherapy in a danish multicenter cohort

HIGHLIGHTS

• who: Frederikke Munck from the Department, Gentofte, Denmark have published the Article: Targeted Axillary Dissection with 125I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort, in the Journal: (JOURNAL) of August/31,/2021

SUMMARY

TAD with 125I seed marking before NACT is feasible without re-marking at surgery and with only minor surgical challenges. Staging with TAD spares 41% of breast cancer patients an axillary dissection. Sentinel lymph node biopsy (SLNB) has been considered for axillary staging in node-positive patients following NACT. Studies report difficulties in identifying the MLN at . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.